Will Ireland follow the UK with free Mounjaro jabs? Minister says assessment to be ready by next year
MOUNJARO, A DRUG used to treat obesity or type-2 diabetes, could be approved for the reimbursement scheme by the next year, according to Health Minister Jennifer Carroll MacNeill.
The so-called 'King Kong' of weight-loss drugs
became available in Ireland
via private prescription in February at a cost of over €215 per month.
Since this week, GPs in the UK are now able to offer Mounjaro for free to severely obese individuals who also suffer from a range of other health complications.
Advertisement
About 220,000 people with 'greatest need' are expected to receive Mounjaro, according to
The Guardian
.
Those eligible to get the prescription free-of-charge in the UK must have a BMI of 40 or over and must have four out of five of the following conditions: type 2 diabetes, high blood pressure, heart and vascular disease, high cholesterol and obstructive sleep apnoea.
When asked today if Ireland will follow such a move, the health minister said Mounjaro, 'is going through the reimbursement process, so I'd expect an outcome of that maybe Q4 this year, Q1 of next year'.
Lilly (formerly known as Eli Lilly) applied to the HSE for reimbursement of the medication for type-2 diabetes (in January 2024) and obesity (last June).
In both cases, the National Centre for Pharmacoeconomics (NCPE) recommended a full health technology assessment (HTA) which will examine the clinical and cost-effectiveness of the drug.
Related Reads
Weight-loss drug Wegovy now available in Ireland
Health Minister: 'There's emerging evidence that Ozempic might be some kind of wonder drug'
Cardiologist: We should welcome the new evidence that Ozempic may slow down ageing
The minister said it is already the case that Saxenda, which is an injection available to adult patients with prediabetes who are at a high-risk of cardiovascular disease, who also have a certain Body Mass Index (BMI), is available on the reimbursement scheme.
The minister went on to state that Ireland is one of the very few countries where obesity has plateaued, in comparison to some other countries in Europe where it is growing.
'I would say very, very strongly, not to take medication that's not prescribed,' said the minister.
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
Learn More
Support The Journal
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Irish Sun
38 minutes ago
- The Irish Sun
I was a ‘fat mum' so jabbed Mounjaro & lost 11st – now I'm asking strangers to pay for surgery to fix my apron belly
A MUM says she "struggles to look at herself naked" after she was left with "saggy skin" when she lost 11st after using Mounjaro jabs. Jade Stalker, 36, weighed 22st 8lbs at her heaviest, after decades of scoffing crisps, 4 After decades of scoffing Chinese takeaways and crisps, Jade, 36, topped the scales at 22st 8lbs Credit: SWNS 4 After forking out for a gastric sleeve and going on Mounjaro, the mum now weighs 11st 8lbs Credit: SWNS 4 Despite feeling 'fantastic', Jade says she's been left with an "overhang on my stomach" and "saggy" boobs due to excess skin Credit: SWNS 4 She has since launched on online funding page seeking to raise £6,000 for surgery to remove excess Credit: SWNS Just before her daughter, now five, started nursery in May 2023, Jade was concerned she'd be seen as one of the 'fat mums' at the school gates - and made a bid to lose 10st. After splashing out £3,500 on flights to Turkey and Now 11st 8lbs, she says she's been left with She has launched on online funding page seeking to raise £6,000 for surgery to remove excess asking from her stomach, breasts and inner thighs. READ MORE ON DIETS Jade, a telecommunications engineer from Sauchie, Scotland, said: 'My skin now is so loose, when I get in the bath, it ripples. 'I have quite a large overhang on my stomach - and my boobs are saggy, despite my doctors telling me they'd get smaller after losing all the weight. 'My partner loves me the way I am - she doesn't care about all that - but I think when you're in a relationship, you do want to look good for your partner.' Jade, who wears men's clothes and started at a 58in waist, says she's never been bothered about her size. Most read in Fabulous She'd have four But becoming a mum changed her view. Watch Ellen's weight loss journey on fat jabs Wanting to teach her daughter 'what a healthy body looks like' she booked flights and a gastric sleeve operation in She could barely eat three-quarters of a burger, after the surgery and lost 5st 8lb in a year. But said the operation hadn't done enough to cure her 'head hunger,' so began a course of Mounjaro via an online pharmacy in October 2024. What to do if you lose too much weight too quickly whilst on Mounjaro IF you're losing too much weight too quickly while on Mounjaro, it's important to take action to avoid potential health risks like muscle loss, malnutrition, dehydration, and fatigue. Here's what you can do: Evaluate Your Caloric Intake Mounjaro reduces appetite, which can make it easy to eat too little. If you're losing weight too fast (more than two to three lbs per week after the initial adjustment period), try: Tracking your food intake to ensure you're eating enough calories (apps like MyFitnessPal can help). Increasing protein intake to preserve muscle mass (aim for 0.6–1g per pound of body weight). Adding healthy fats and complex carbs (e.g., avocados, nuts, whole grains) for balanced energy. Adjust Your Dosage (With Doctor's Approval) If your weight loss is too rapid or causing side effects, your doctor may: Pause dose increases or lower your dosage. Adjust your treatment plan to stabilise your weight loss. Strength Training & Exercise To prevent muscle loss: Incorporate resistance training at least two to three times per week. Stay active with low-impact exercises like walking or yoga. Hydrate & Manage Electrolytes Drink enough water (Mounjaro can reduce thirst). Electrolytes matter - Consider adding magnesium, sodium, and potassium if you feel weak or fatigued. Monitor for Malnutrition & Deficiencies Rapid weight loss can cause vitamin/mineral deficiencies (especially B12, iron, and electrolytes). If you experience: Fatigue, hair loss, or dizziness, ask your doctor about supplements. Consider Further Medical Guidance If your weight loss is excessive or causing health concerns, speak with your healthcare provider. They might adjust your dosage, diet, or exercise plan to help stabilise your weight loss. 'The only thing that made me less mentally hungry was "Being on it is like walking through Tesco when you've just had a huge meal.' She lost a further 5st 2lb. She noticed "saggy skin" early into her She added: 'I'd say my most conscious areas are my stomach, my boobs and my inner thighs - although I'm quite a 'I've held off from doing a Jade's meals before and now Before weight loss: Breakfast: Four ham rolls Lunch: A Tesco meal deal, with an extra bag of crisps and a chocolate bar Dinner: A Chinese takeaway, fish and chips, or 'man-sized' plate of spaghetti Bolognese with garlic bread Snacks: Nuts, a late-night bag of sweets After losing weight: Breakfast: Two slices of toast, with butter Lunch: Meal deal wrap, with yoghurt and a Ribena Light Dinner: Halloumi wrap with salad inside Snack: Light yoghurt.
Extra.ie
an hour ago
- Extra.ie
€8,414: Cost of keeping a patient in hospital for week
The cost of keeping a patient in hospital for one week is approaching an average of €8,500. This compares with a weekly average cost of €2,000 in stepdown care facilities, an Oireachtas committee has heard, with Health Minister Jennifer Carroll MacNeill now seeking more capital funding for such centres. Today's top videos STORY CONTINUES BELOW Step-down facilities provide a bridge between hospital care and a return to the patient's home or a long-term care facility. These centres are frequently used by older populations and are commonly located in nursing homes under both public and private ownership. Jennifer Carroll MacNeill. Pic: Stephen Collins/ Collins Photos Fine Gael TD Colm Burke raised the lack of step-down beds in Ireland with the Health Minister yesterday, highlighting the impact the facilities can have on 'freeing up hospital beds'. Mr Burke, who has sat on the health committee since 2011, raised the case of a man in his 30s who suffered a stroke and required rehabilitation services. 'Instead, that man occupied a bed in a public hospital for four months,' Mr Burke said. 'Are we doing everything in our power to identify step-down facilities? The whole idea of [these centres] is that they are located near hospitals and can free up beds in a faster time frame,' he added. Pic: Shutterstock Mr Burke also highlighted the financial benefit of step-down care. 'Every person in hospital is costing the State roughly €8,000 per week. However, if you have a step-down facility, the most it will cost is €2,000 per week. We need to look at step-down facilities to get people out of hospitals,' he said. The most up-to-date data published by the HSE shows that as of June 2024, the average 'fully absorbed', of keeping a patient in hospital is €1,202 per day. This equates to €8,414 per week and covers treatment costs and the cost of running the hospital. Colm Burke. Pic: Gareth Chaney/Collins Photos Speaking to Mr Burke noted that the average daily cost of keeping a patient in hospital has increased, with the figure standing at €1,195 per day or €8,365 per week in 2023, up from €878 a day and €6,146 a week in 2019. In light of cost pressures, this could soon place the weekly cost of hospital care to the Exchequer at €8,500 per patient. Data provided to Mr Burke estimates that the weekly cost of step-down care in nursing homes can range from €1,206 to €1,969. The Cork TD said: 'There were 781,300 people over the age of 65 recorded in the last Census. This cohort is expected to grow to one million people by 2030. Over half of hospital beds are being occupied by over-65s. 'We can build step-down facilities quicker than hospitals – we have to build more of them all over the country.' Speaking at the health committee meeting, Ms Carroll MacNeill told Mr Burke she 'could not agree with [him] more'. 'That is why I am looking for capital investment in community nursing homes and step-down facilities… because it is a much more efficient way of looking after someone from a financial perspective and it is a much better way of meeting their needs,' the minister said. She added that the issue of people staying in hospital longer than necessary is of 'particular concern' to her department. 'I look at the hospital trolley figures every single day and I am aware that in some hospitals, particularly in hospitals across the west, delayed discharge is a key metric [in high trolley numbers];' She added: 'Step-down facilities are essential. 'We are not going to be able to meet today's needs, let alone tomorrow's needs, without significant capital investment. We have a plan in our NDP [National Development Plan] review to be able to do that… We need to build new [step-down facilities].'
Irish Times
3 hours ago
- Irish Times
Hundreds of weight loss and diabetes jab users in UK report pancreas problems
Hundreds of people in the UK have reported problems with their pancreas linked to taking weight loss and diabetes injections, prompting health officials to begin a study into side-effects. Some cases of pancreatitis reported to be linked to GLP-1 medicines (glucagon-like peptide-1 receptor agonists) have been fatal. The move comes after an increase in reports of acute pancreatitis to the Medicines and Healthcare products Regulatory Agency's (MHRA) Yellow Card scheme, which monitors any adverse reactions to medications and medical devices in the UK. Acute pancreatitis is a sudden inflammation of the pancreas, a gland located behind the stomach that aids in digestion. It often requires hospital admission. Symptoms include severe pain in the abdomen, nausea and fever. READ MORE Patient information leaflets for GLP-1 medications list pancreatitis as an 'uncommon' reaction, affecting about one in 100 patients. To date, the scheme has received nearly 400 reports of acute pancreatitis from patients who have used Mounjaro, Wegovy , Ozempic and liraglutide, with nearly half (181) involving tirzepatide (Mounjaro). More than one quarter of these cases have been reported in 2025. Since the beginning of the year, there have been 22 reports of acute pancreatitis after taking semaglutide (Ozempic and Wegovy), and 101 after taking tirzepatide (Mounjaro) to the Yellow Card scheme. An MHRA spokesperson said: 'Alongside increased usage, we are seeing an upturn in the number of Yellow Card reports mentioning GLP-1 medicines and acute pancreatitis.' Due to the impact of this serious disease on patients, the MHRA said it wanted to understand whether there were any genetic factors at play. It has encouraged anyone hospitalised with acute pancreatitis suspected to be related to taking these drugs to report it to the Yellow Card scheme. Health professionals are also urged to report to the scheme on behalf of their patients. The MHRA will then invite those patients to take part in the Yellow Card Biobank study, run by Genomics England. Participants will be asked to provide further information, alongside a saliva sample, which will be analysed by scientists. Although there is no known genetic link that increases the risk of acute pancreatitis while taking GLP-1 medicines, the MHRA said: 'Sometimes genes can influence the side-effects an individual experiences when taking a medicine, so in the context of the increasing usage of these medicines and the reports of acute pancreatitis we have received, we are exploring this further.' Studies have shown that adverse reactions to medication account for one in six hospital admissions in the UK. Dr Alison Cave, the MHRA's chief safety officer, said: 'Evidence shows that almost a third of side-effects to medicines could be prevented with the introduction of genetic testing. It is predicted that adverse drug reactions cost the NHS more than £2.2bn a year in hospital stays alone.' A spokesperson for Lilly, the maker of Mounjaro, said: 'Patient safety is Lilly's top priority. 'We take reports regarding patient safety seriously and actively monitor, evaluate and report safety information for all our medicines. Adverse events should be reported under the MHRA's Yellow Card scheme, but may be caused by other factors, including pre-existing conditions. 'The Mounjaro (tirzepatide) patient information leaflet warns that inflamed pancreas (acute pancreatitis) is an uncommon side-effect (which may affect up to 1 in 100 people). It also advises patients to talk to their doctor or other healthcare professional before using Mounjaro if they have ever had pancreatitis.' A spokesperson for Novo Nordisk UK, which makes Ozempic and Wegovy, said: 'Patient safety is of the utmost importance to Novo Nordisk. Like all medications, side effects can occur and vary from patient to patient. The known risks and benefits of GLP1 medicines are described in the summary of product characteristics. 'We recommend that patients take these medications only for their approved indications and under the strict supervision of a healthcare professional, who can also advise on potential side effects. 'We continuously collect safety data on our marketed GLP-1 medicines and work closely with the authorities to ensure patient safety. The benefit-risk profile of our GLP-1 medicines remains positive, and we welcome any new research that will improve our understanding of treatments for people living with chronic diseases.' - Guardian
